Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Clinical trial NCT03359239 · COMPLETED

Trial details

NCT number: NCT03359239
Sponsor: Matthew Galsky
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urothelial/Bladder Cancer, Nos

Start date: 2019-05-08
Primary completion: 2021-10-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.